Works matching IS 00070920 AND DT 2024 AND VI 131 AND IP 4
Results: 20
Correction: Impact of the COVID-19 pandemic on breast cancer patient pathways and outcomes in the United Kingdom and the Republic of Ireland – a scoping review.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
Comment on: "A nationwide study of breast reconstruction after mastectomy in patients with breast cancer receiving postmastectomy radiotherapy: comparison of complications according to radiotherapy fractionation and reconstruction procedures".
- Published in:
- 2024
- By:
- Publication type:
- Letter
Correction: Epithelial−mesenchymal transition induced by tumor cell-intrinsic PD-L1 signaling predicts a poor response to immune checkpoint inhibitors in PD-L1-high lung cancer.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
Prognostic significance of PET/CT and its association with immuno-genomic profiling in oesophageal squamous cell carcinoma treated with immunotherapy plus chemoradiotherapy: results from a phase II study.
- Published in:
- British Journal of Cancer, 2024, v. 131, n. 4, p. 709, doi. 10.1038/s41416-024-02779-4
- By:
- Publication type:
- Article
A population-based study on trajectories of HER2 status during neoadjuvant chemotherapy for early breast cancer and metastatic progression.
- Published in:
- British Journal of Cancer, 2024, v. 131, n. 4, p. 718, doi. 10.1038/s41416-024-02777-6
- By:
- Publication type:
- Article
Optimizing adjuvant treatment strategies for non-pancreatic periampullary cancers.
- Published in:
- 2024
- By:
- Publication type:
- Editorial
Treatment outcome according to genetic tumour alterations and clinical characteristics in digestive high-grade neuroendocrine neoplasms.
- Published in:
- British Journal of Cancer, 2024, v. 131, n. 4, p. 676, doi. 10.1038/s41416-024-02773-w
- By:
- Publication type:
- Article
Synergy of retinoic acid and BH3 mimetics in MYC(N)-driven embryonal nervous system tumours.
- Published in:
- British Journal of Cancer, 2024, v. 131, n. 4, p. 763, doi. 10.1038/s41416-024-02740-5
- By:
- Publication type:
- Article
KDM1A, a potent and selective target, for the treatment of DNMT3A-deficient non-small cell lung cancer.
- Published in:
- British Journal of Cancer, 2024, v. 131, n. 4, p. 655, doi. 10.1038/s41416-024-02772-x
- By:
- Publication type:
- Article
Hormone replacement therapy and cancer mortality in women with 17 site-specific cancers: a cohort study using linked medical records.
- Published in:
- British Journal of Cancer, 2024, v. 131, n. 4, p. 737, doi. 10.1038/s41416-024-02767-8
- By:
- Publication type:
- Article
Efficacy of administration sequence: Sacituzumab Govitecan and Trastuzumab Deruxtecan in HER2-low metastatic breast cancer.
- Published in:
- British Journal of Cancer, 2024, v. 131, n. 4, p. 702, doi. 10.1038/s41416-024-02766-9
- By:
- Publication type:
- Article
Social determinants of health inequalities in early phase clinical trials in Northern England.
- Published in:
- British Journal of Cancer, 2024, v. 131, n. 4, p. 685, doi. 10.1038/s41416-024-02765-w
- By:
- Publication type:
- Article
Quality of life for patients with advanced gastrointestinal cancer randomised to early specialised home-based palliative care: the ALLAN trial.
- Published in:
- British Journal of Cancer, 2024, v. 131, n. 4, p. 729, doi. 10.1038/s41416-024-02764-x
- By:
- Publication type:
- Article
Cancer risk in individuals with polydactyly: a Swedish population-based cohort study.
- Published in:
- British Journal of Cancer, 2024, v. 131, n. 4, p. 755, doi. 10.1038/s41416-024-02770-z
- By:
- Publication type:
- Article
A non-invasive artificial intelligence model for identifying axillary pathological complete response to neoadjuvant chemotherapy in breast cancer: a secondary analysis to multicenter clinical trial.
- Published in:
- British Journal of Cancer, 2024, v. 131, n. 4, p. 692, doi. 10.1038/s41416-024-02726-3
- By:
- Publication type:
- Article
Dramatic improvements in outcome following pancreatoduodenectomy for pancreatic and periampullary cancers.
- Published in:
- British Journal of Cancer, 2024, v. 131, n. 4, p. 747, doi. 10.1038/s41416-024-02757-w
- By:
- Publication type:
- Article
QL1209 (pertuzumab biosimilar) versus reference pertuzumab plus trastuzumab and docetaxel in neoadjuvant treatment for HER2-positive, ER/PR-negative, early or locally advanced breast cancer: A multicenter, randomized, double-blinded, parallel-controlled, phase III equivalence trial
- Published in:
- British Journal of Cancer, 2024, v. 131, n. 4, p. 668, doi. 10.1038/s41416-024-02751-2
- By:
- Publication type:
- Article
MT1G induces lipid droplet accumulation through modulation of H3K14 trimethylation accelerating clear cell renal cell carcinoma progression.
- Published in:
- British Journal of Cancer, 2024, v. 131, n. 4, p. 641, doi. 10.1038/s41416-024-02747-y
- By:
- Publication type:
- Article
Clinical landscape of macrophage-reprogramming cancer immunotherapies.
- Published in:
- British Journal of Cancer, 2024, v. 131, n. 4, p. 627, doi. 10.1038/s41416-024-02715-6
- By:
- Publication type:
- Article
Impact of the COVID-19 pandemic on breast cancer patient pathways and outcomes in the United Kingdom and the Republic of Ireland – a scoping review.
- Published in:
- British Journal of Cancer, 2024, v. 131, n. 4, p. 619, doi. 10.1038/s41416-024-02703-w
- By:
- Publication type:
- Article